EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bridging the phenotype-target gap for molecular generation via multi-objective reinforcement learning

Haotian Guo, Hui Liu iD

Bioinformatics · 01.07.2026 · 42 (Supplement_1)

DOI: 10.1093/bioinformatics/btag242 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioinformatics, online erschienen am 07.07.2026. Verfasst von Haotian Guo und 1 weiteren Autor:innen. Beteiligte Einrichtung: College of Computer and Information Engineering, Nanjing Tech University, Nanjing, Jiangsu 211800, China. Hauptthemen laut MEDLINE: Drug Design, Computational Biology, Drug Discovery. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Motivation The generation of high-quality candidate molecules remains a central challenge in AI-driven drug design. Current phenotype-based and target-based strategies each suffer limitations, either incurring high experimental costs or overlooking system-level cellular responses. To bridge this gap, we propose XMolRL, a novel generative framework that synergistically integrates phenotypic and target-specific cues for de novo molecular generation. Results The phenotype-guided generator is first pretrained on expansive drug-induced transcriptional profiles and subsequently fine-tuned via multi-objective reinforcement learning (RL). Crucially, the reward function fuses docking affinity and drug-likeness scores, augmented with ranking loss, prior-likelihood regularization, and entropy maximization. The multi-objective RL steers the model toward chemotypes that are simultaneously potent, diverse, and aligned with the specified phenotypic effects. Extensive experiments demonstrate XMolRL’s superior performance over state-of-the-art phenotype-based and target-based models across multiple well-characterized targets. Our generated molecules exhibit favorable drug-like properties, high target affinity, and inhibitory potency (IC50) against cancer cells. This unified framework showcases the synergistic potential of combining phenotype-guided and target-aware strategies, offering a more effective solution for de novo drug discovery. Availability and implementation The source code and datasets are available at: https://github.com/hliulab/XMolRL. The archived version of the source code and test data can be found at: https://doi.org/10.5281/zenodo.19607680.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug DesignComputational BiologyDrug DiscoveryReinforcement Machine LearningPhenotypeHumansAlgorithmsGenerative Artificial Intelligence

Autor:innen und Institutionen

  • College of Computer and Information Engineering, Nanjing Tech University, Nanjing, Jiangsu 211800, China.

ORCID-Profile: Hui Liu

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Jiangsu Province

Zitieren

APA

Guo, H., & Liu, H. (2026). Bridging the phenotype-target gap for molecular generation via multi-objective reinforcement learning. Bioinformatics, 42(Supplement_1). https://doi.org/10.1093/bioinformatics/btag242

Vancouver

Guo H, Liu H. Bridging the phenotype-target gap for molecular generation via multi-objective reinforcement learning. Bioinformatics. 2026;42(Supplement_1). doi:10.1093/bioinformatics/btag242

BibTeX
@article{Guo2026,
  author = {Guo, Haotian and Liu, Hui},
  title = {Bridging the phenotype-target gap for molecular generation via multi-objective reinforcement learning},
  journal = {Bioinformatics},
  year = {2026},
  volume = {42},
  number = {Supplement_1},
  doi = {10.1093/bioinformatics/btag242}
}
Kostenlos starten →